Chinese Cordyceps : Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review

Chinese Cordyceps is a valuable source of natural products with various therapeutic effects. It is rich in various active components, of which adenosine, cordycepin and polysaccharides have been confirmed with significant immunomodulatory and antitumor functions. However, the underlying antitumor mechanism remains poorly understood. In this review, we summarized and analyzed the chemical characteristics of the main components and their pharmacological effects and mechanism on immunomodulatory and antitumor functions. The analysis revealed that Chinese Cordyceps promotes immune cells' antitumor function by via upregulating immune responses and downregulating immunosuppression in the tumor microenvironment and resetting the immune cells' phenotype. Moreover, Chinese Cordyceps can inhibit the growth and metastasis of tumor cells by death (including apoptosis and autophagy) induction, cell-cycle arrest, and angiogenesis inhibition. Recent evidence has revealed that the signal pathways of mitogen-activated protein kinases (MAPKs), nuclear factor kappaB (NF-κB), cysteine-aspartic proteases (caspases) and serine/threonine kinase Akt were involved in the antitumor mechanisms. In conclusion, Chinese Cordyceps, one type of magic mushroom, can be potentially developed as immunomodulator and anticancer therapeutic agents.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:27

Enthalten in:

Molecules (Basel, Switzerland) - 27(2022), 19 vom: 04. Okt.

Sprache:

Englisch

Beteiligte Personen:

Liu, Yan [VerfasserIn]
Guo, Zhi-Jian [VerfasserIn]
Zhou, Xuan-Wei [VerfasserIn]

Links:

Volltext

Themen:

452VLY9402
Adenosine
Antineoplastic Agents
Antitumor
Bioactive components
Biological Products
Caspases
Chinese Cordyceps
Cysteine
EC 2.7.11.1
EC 2.7.11.24
EC 3.4.22.-
Immunologic Factors
Immunomodulatory
Journal Article
K72T3FS567
K848JZ4886
Mechanism
Mitogen-Activated Protein Kinases
NF-kappa B
Proto-Oncogene Proteins c-akt
Review
Serine

Anmerkungen:

Date Completed 17.10.2022

Date Revised 19.10.2022

published: Electronic

Citation Status MEDLINE

doi:

10.3390/molecules27196576

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM347501761